CV redatto in forma di autocertificazione ai sensi degli artt. 46 e 47 del D.P.R. 445/2011 e s.m.i.

CURRICULUM VITAE

Dr. Marco Dauriz

Nome: Marco

Cognome: Dauriz

Sesso: M

Data di nascita: 21 giugno 1982

Luogo di nascita: Trento, Italy

Titoli di Studio

Medico Chirurgo (M.D.) Specialista in Endocrinologia e Malattie del Metabolismo Dottore di Ricerca in Scienze Mediche, Cliniche e Sperimentali (Ph.D.)

Istituzione

Divisione di Endocrinologia, Diabetologia e Malattie del Metabolismo Dipartimento di Medicina Università e AOUI di Verona Piazzale Stefani, 1 – Pad. 22 37126 Verona – Italy

Posizione attuale

Assistant Professor of Endocrinology, Diabetes and Metabolism Sezione di Endocrinologia, Diabetologia e Malattie del Metabolismo Dipartimento di Medicina, Università di Verona, VR – Italy Honorary Consultant in Endocrinology, Diabetes and Metabolism Divisione di Endocrinologia, Diabetologia e Malattie del Metabolismo Dipartimento Medico Generale, Azienda Ospedaliera Universitaria Integrata di Verona, VR - Italy Contatti Indirizzo E-mail: marco.dauriz@univr.it Telefono (lavoro): +39 (045) 812-3110 Fax (lavoro): +39 (045) 802-7314

2

FORMAZIONE Anno 2001 Diploma di maturità classica presso Liceo Classico “Giovanni Prati”, Trento, Italy

2001-2002 Studente presso l’Università di Trento, Facoltà di Ingegneria, Corso di Laurea

specialistica quinquennale in Ingegneria Edile/Architettura, Trento, Italy 2002-2008 Studente presso l’Università degli Studi di Verona, Facoltà di Medicina e Chirurgia,

Corso di Laurea specialistica in Medicina e Chirurgia, Verona, Italy Feb 2007- Gen 2009 Studente interno presso il Dipartimento di Medicina, Sezione di Endocrinologia e e

Mallattie del Metabolismo, Università degli Studi di Verona, Facoltà di Medicina e Chirurgia, Verona, Italy

Ott 2008 Diploma di Laurea in Medicina e Chirurgia, Università degli Studi di Verona,

Facoltà di Medicina e Chirurgia, Verona, Italy

Mar 2009 Esame di Stato per l’Abilitazione all’esercizio della professione di Medico Chirurgo Mar 2009-(oggi) Iscrizione all’Ordine dei Medici Chirurghi e degli Odontoiatri della Provincia

Autonoma di Trento (TN 3860), Trento, Italy

Giu 2009-Lug 2014 Scuola di Specializzazione quinquennale di Endocrinologia e Malattie del Metabolismo, Dipartimento di Medicina, Università degli Studi di Verona, Facoltà di Medicina e Chirurgia, Verona, Italy

Lug-Dic 2009 Resident presso Divisione di Medicina Interna D, Policlinico Universitario di

Verona, Verona, Italy

Gen-Apr 2010 Resident presso Divisione di Endocrinologia, Diabete e Metabolismo, Ospedale Civile Maggiore, Verona, Italy

Mag-Dic 2010 Resident presso Divisione di Medicina Interna, Ospedale “S. Chiara”, Trento, Italy

Gen 2011-Giu 2014 Endocrine Fellow presso Divisione di Endocrinologia, Diabete e Metabolismo,

Dipartimento di Medicina, Ospedale Civile Maggiore, AOUI di Verona, Verona, Italy

Gen 2013-Dic 2015 PhD Candidate, Corso di Dottorato in Scienze Mediche, Cliniche e Sperimentali,

Scuola di Dottorato in Scienze della Vita e della Salute, Università di Verona, Verona, Italy

Feb 2013-Giu 2014 Postdoctoral Research Fellow presso Massachusetts General Hospital-Harvard

Medical School, General Medicine Division, Boston, Massachusetts, U.S.A. Lug 2014 Diploma di Specializzazione in Endocrinologia e Malattie del Metabolismo

(70/70 cum laude), Università di Verona, Scuola di Medicina, Verona, Italy Giu 2015 Visiting Fellow presso Massachusetts General Hospital-Harvard Medical School,

General Medicine Division, Boston, Massachusetts, U.S.A. Mentor: Prof. James B. Meigs Mag 2016 Diploma di Dottorato di ricerca (Ph.D.) in Scienze Mediche, Cliniche e Sperimentali

– Scuola di Dottorato in Scienze della Vita e della Salute, Università di Verona Mentors: Prof. E. Bonora; Prof. J.B. Meigs; Prof. R.C. Bonadonna

3

Posizioni accademiche e ambito di studio

2001-2002 Posizione: studente Ambito di studio: ingegneria di base, elementi di programmazione, analisi

computazionale e codifica per l’analisi matematica, geometria analitica e vettoriale, elementi di architettura e ingegneria edile.

2002-2008 Posizione: studente Ambito di studio: Medicina e Chirurgia

2007-2009 Posizione: studente interno Ambito di studio: minimal modeling e analisi dei dati di clamp euglicemico

iperinsulinemico e carico orale di glucosio in paziente affetti da diabte tipo 2 di nuova diagnosi. Elementi di genetica di diabete e fenotipi cardiometabolici (da geni candidate ai primi GWAS).

2009-2010 Posizione: resident (medicina interna) Ambito di studio: attività clinica di reparto e ambulatoriale; management,

coordinazione e analisi del database del Centro Diabetologico dell’Ospedale S. Chiara di Trento, Trento, Italy

2011-2014 Posizione: fellow in endocrinologia, diabetologia e malattie del metabolsimo Ambito di studio: oltre all’attività clinico-assistenziale ambulatoriale e di reparto,

co-investigator coinvolto nel disegno, recltamento, fenotipizzazione, coordinamento, analisi dei dati e presentazione di parecchi clinical trial relative a diabete di tipo 1 (pancreas artificiale, modellazione di sistemi di infuzione insulinica ad ansa chiusa, semiautomatici) e tipo 2, fenotipi di rischio aterosclerotico, obesità e fenotipi intermedi di rischio cardiovascolare; minimal modeling di OGTT, IVGTT, MMT e dati di clamp iperinsulinemico in soggetti diabetic di tipo 1 e tipo 2.

2013-2015 Posizione: PhD candidate Ambito di studio: Determinanti genetici di diabete tipo 2, malattie

cardiometaboliche e fenotipi/tratti intermedi.

2013-2014 Posizione: post-doctoral research fellow Ambito di studio: genetica medica e di popolazione: determinant genetici di diabete,

obesità, malattie cardiovascolari e tratti intermedi. Disegno di progetti di ricerca, coordinamento e management di team di ricerca internazionali, analisi e presentazione dei dati. Partecipazione attiva e presentazioni orali a numerosi meeting locali e internazionali. Scrittura scientifica. Attività di revision per riviste scientifiche. Partecipazione a meeting scientifici e a corsi di statistica presso la Boston University, Harvard University, Massachusetts Institute of Technology, Broad Institute.

2016 Posizione: Dirigente Medico I livello – disciplina: Endocrinologia / Alte tecnologie (AOUI Verona); Research Associate (Università di Verona)

2017 Posizione: Ricercatore t.d. tipo A in assistenza clinica – disciplina: Endocrinologia Università e AOUI di Verona

Tesi Ott 2008 Tesi di Laurea Specialistica in Medicina e Chirurgia:

“Caratteristiche della risposta beta-cellulare al glucosio nel soggetto normale e nel paziente con diabete di tipo 2” - Relatore: Prof. M. Muggeo, MD; Correlatore: Prof. R. C. Bonadonna, MD

Lug 2014 Tesi di Specializzazione in Endocrinologia e Malattie del Metabolismo: “Associazione di uno score di 62 varianti genetiche di rischio per diabete tipo 2 con

indici di ateroscleroi subclinica in coorti multietniche” - Relatore: Prof. E. Bonora, MD, PhD; Correlatore: Prof. J. B. Meigs, MD, MPH

Mag 2016 Tesi di Dottorato: “Genetic determinants of type 2 diabetes and associated cardiometabolic disorders /Determinanti genetici di diabete mellito di tipo 2 e fenotipi cardiometabolici associati” - Tutor: Prof. E. Bonora, MD, PhD; Co-tutors: Prof. J. B. Meigs, MD, MPH; Prof. Riccardo C. Bonadonna, MD

4

Borse di studio e premi

Nov 2015 Migliore Comunicazione Orale al Congresso Congiunto SID-AMD Sezione Veneto-

Trentino-Alto Adige/Friuli-Venezia-Giulia 2016: “Moderate levels of physical activity during free-living conditions are associated with higher insulin sensitivity but not beta-cell function in patients with newly-diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)”

Set 2015 Parma Diabetes Medal, awarded by the Italian Society of Diabetes (S.I.D.) for the

research conducted in the field of “Genetic determinants of type 2 diabetes and associated cardiometabolic disorders”

Mag 2015 Migliore Comunicazione Orale al XVI Convegno Annuale della Società Italiana per

lo Studio dell’Aterosclerosi (S.I.S.A.) – Sezione Nord-Est, Verona, Italy: “Associazione della variabilità genetica commune dei loci IRS1, TRIB3, ENPP1 con fenotipi metabolici e tratti di rischio cardiovascolare in pazienti affetti da diabete tipo 2 neo-diagnosticato. The Verona Newly Diagnosed type 2 Diabetes Study”

Nov 2014 Migliore Comunicazione Orale al Congresso Congiunto SID-AMD Sezione Veneto-

Trentino-Alto Adige 2014: “Uno score di 44 varianti genetiche di rischio per nefropatia è associate a ridotto filtrate glomerulare in pazienti con diabete tipo 2 neodiagnoticato.”

Set 2014 Vincitore di Grant di Ricerca dell’Università di Verona per il progetto: “Association

of Common Cardiometabolic Genetic Variants with Mortality in the Framingham Heart Study – SNP Health Association Resource (FHS SHARe Study)”

Mar 2014 Migliore abstract scientifico “Association of levels of fasting glucose and insulin

with rare variants at the chr11p11.2-MADD locus: a CHARGE Consortium Targeted Sequencing Study”, selezionato per Comunicazione Orale al 2014 American Heart Association EPI/NPAM 2014 Scientific Meeting, San Francisco, CA, U.S.A.

Mag 2013 Vincitore della Borsa di Ricerca e Mobilità Internazionale “CooperInt Junior

Researcher Program 2012” rilasciata dall’Università degli Studi di Verona (Fondi 5x1000) per il seguente progetto: “Genetics of Type 2 Diabetes and Cardiovascular Diseases in the Framingham Heart Study – SNP Health Association Resource (FHS SHARe Study)”

Set 1997 Borsa di Studio per merito (anno scolastico 1997/1998), Liceo Classico “Giovanni

Prati”, Trento, Italy Competenze linguistiche

Italiano Nativo (C2*, parlato e scritto)§

Inglese Fluente (C2*, parlato e scritto - TOEFL)

Tedesco Professionale (C1*, parlato e scritto - Goethe-Zertifikat)§

§Zweisprachigkeit Urkunde “A” (BZ) *quadro comune europeo di riferimento per le lingue

Altre certificazioni

Set 2014 BLS/AED Certification - provided by the Italian Resuscitation Council

Ott 2016 ALS Certification – rilasciato da IRC/ERC

5

ATTIVITÀ CLINICA

2009-2014 Attività clinica di reparto e ambulatoriale (full-time): -Divisione di Medicina Interna, AOUI di Verona, Verona, Italy -Divisione di Medicina Interna, Ospedale S. Chiara di Trento, Trento, Italy -Divisione di Endocrinologia, Diabetologia e Metabolismo, AOUI di Verona,

Verona, Italy 2010-2013 Servizio di Continuità Assistenziale - APSS di Trento, Trento, Italy 2014-2015 Medico Specialista in L.P., area Medico-Endocrinologica - AOUI di Verona, Verona, Italy 2016 Dirigente Medico I livello – Specialista in Endocrinologia, Diabetologia e Malattie del

Metabolismo (full-time); Divisione di Endocrinologia, Diabetologia e Malattie del Metabolismo – Dipartimento di Medicina, AOUI di Verona, Verona, Italy

Dic 2016-oggi Ricercatore t.d. tipo A in assistenza clinica (full-time) – Divisione di Endocrinologia,

Diabetologia e Malattie del Metabolismo – Dipartimento di Medicina, AOUI di Verona, Verona, Italy

Supervisione clinica 2016 Supervisore clinico di 2 medici specializzandi in Endocrinologia e Malattie del

Metabolismo (attività di reparto e consulenza) 2017 Supervisore clinico di 3 medici specializzandi in Endocrinologia e Malattie del

Metabolismo (attività di reparto e consulenza) 2018 Supervisore clinico di 3 medici specializzandi in Endocrinologia e Malattie del

Metabolismo (attività di reparto e consulenza)

6

ATTIVITÀ SCIENTIFICA

Aree di interesse

- Epidemiologia e genetica di diabete mellito e malattie cardiovascolari - Bioarchitettura e modellazione dei sistemi metabolici (microinfusori insulinici e sistemi di infusione

insulinica semi-automatici) - Endocrinologia e metabolismo intermedio

Società Scientifiche

- Società Italiana di Diabetologia (membro dal 2012) Dal 2016: membro del Comitato Editoriale

- Società Italiana di Endocrinologia (membro dal 2013) - American Diabetes Association – ADA (membro dal 2017) - European Association for the Study of Diabetes – EASD (membro dal 2014) - Società Italiana per lo Studio dell’Aterosclerosi – SISA (membro dal 2015)

Attività di revisione 2013 Abstract grader for the AHA EPI/NPAM 2014 Scientific Meeting, San Francisco, CA, USA

2014 Abstract grader for the AHA EPI/Lifestyle 2015 Scientific Meeting, Baltimore, MA, USA

2014 - Reviewer per le seguenti riviste scientifiche: Diabetes Care; Diabetologia (amongst top Reviewers in

oggi 2016 & 2017); The Journal of Clinical Endocrinology and Metabolism; Endocrinology; PLoS ONE;

Scientific Reports (since 2015); Nutrition & Diabetes (since 2016); Diabetes (since 2016);

Cardiovascular Diabetology (since 2016); Nutrition, Metabolism & Cardiovascular Diseases

(NMCD, since 2017); International Journal of Cardiology, BMC Medical Genetics (since 2017);

Atherosclerosis; Diabetic Medicine, Journal of Clinical and Translational Endocrinology, Annals of

Trsanslational Medicine, Endocrine Reviews, Diabetes-Metabolism-Research & Reviews (since 2018)

2015 Abstract grader for the AHA EPI/Lifestyle 2016 Scientific Meeting, Phoenix, AZ, USA

Distinguished Evaluator for the 2015 Excellence Initiative “Severo Ochoa” by invitation from the

Spanish Government, Secretariat of State for Research, Development and Innovation, Ministry of

Economy and Competitiveness, Madrid, Spain

2016 Curatore Editoriale del Journal Club mensile della Società Italiana di Diabetologia, sezione di

“Epidemiologia del diabete e suoi fattori di rischio; costi e modelli assistenziali”

(http://www.siditalia.it/ricerca/journal-club/epidemiologia-del-diabete)

2018 Editorial Board Member of “Diabetes/Metabolism: Research & Reviews (DMRR)” (IF: 3.904; ISI

JCR Ranking: 2016: 39/143 Endocrinology & Metabolism)

Supervisione tesi di laurea in Medicina e Chirurgia

2017-2018 M.D. Graduation Thesis Co-advisor. Head advisor: prof. Enzo Bonora. Candidate #1: Title: “Epidemiology of diabetes mellitus in patients admitted to the

intensive cardiac care unit of the University of Verona Hospital Trust over 2015-2016” Candidate #2: Title: “Epidemiology of diabetes mellitus in patients admitted to the stroke

unit of the University of Verona Hospital Trust over 2015-2016”

7

Interventi Congressuali e relazioni su invito

2017 Mendel C.S.S. Insistitute - Fondazione Casa Sollievo della Sofferenza Roma – Italy, Oct 13th, 2017

Invited seminar: “The genetic landscape of type 2 diabetes: from risk association to biological insights”

2016 Trentino Autonomous Region – Associazione Trentina Diabetici – 2016 ATD Annual Meeting

Trento, Alto Adige/Südtirol Autonomous Region – Italy, May 21st 2016 Invited seminar: “Genetics and new technologies in diabetes: applications and perspectives”

2016 2016 ATD Annual Meeting - May 21st 2016, Trento – Italy

Invited seminar: “Genetics and new technologies in diabetes: applications and perspectives” 2015 Parma Diabetes 2015 - 10th Scientific Meeting Oct 29-30th, 2015, Parma – Italy

Invited seminar: “Genetic determinants of type 2 diabetes and associated cardiometabolic disorders” – A 3-yearly initiative of the Italian Society of Diabetes (SID)

Deutsches Diabetes-Zentrum (DDZ), Leibniz-Zentrum für Diabetes-Forschung an der Heinrich-Heine-Universität Düsseldorf, Düsseldorf – Germany, Aug 25th 2015

Invited seminar: “Genetics and functional phenotyping of diabetes”

European Association for the Study of Diabetes (EASD) - 51st Scientific meeting. Stockholm – Sweden; Sep 14-18th, 2015

Oral presentation: “Pancreatic beta cell function, insulin sensitivity and metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona newly diagnosed type 2 diabetes study”

2014 EURAC Research, Center for Biomedicine, May 19th 2014

Invited seminar: “Genetics of Type 2 Diabetes and Intermediate Traits: from Association to Function” – Organized by the Center for Biomedicine, European Academy Research (EURAC), Bolzano/Bozen, South Tirol, Italy.

American Heart Association - Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2014 Scientific Sessions, March 18-21, San Francisco, California. Oral presentation: “A newly identified rare variant (chr11:47227430) with possible functional activity is associated with fasting insulin at the chromosome 11p11.2-NR1H3 locus in the Cohorts for Heart and Aging Research in Genetic Epidemiology Targeted Sequencing Study (CHARGE-TSS)”

2012 Workshop on Endocrinology and Metabolism, Verona, Italy.

Oral presentation: “Genetics and diabetes mellitus: Clinical Cases” – Organized by Department of Medicine, Section of Endocrinology and Metabolic Diseases, University of Verona School of Medicine, Verona, Italy

2011 Workshop on Endocrinology and Metabolism, Verona, Italy. Oral presentation: “Guidelines on Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring for the treatment of diabetes mellitus” – Organized by Department of Medicine, Section of Endocrinology and Metabolic Diseases, University of Verona School of Medicine, Verona, Italy

8

Pubblicazioni scientifiche Impact

Factor JCR 2016

1. Metabolism: Clinical and Experimental, 2018 Jun 20. pii: S0026-0495(18)30138-0 – PMID: 29935236 Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. Mantovani A, Dauriz M, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G.

5.777

2. Journal of Clinical Apheresis, 2018 Apr – PMID: 29638018 Case report - Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia. Zenti MG, Stefanutti C, Sanga V, Altomari A, Fabris A, Dauriz M, Bonora E.

1.835

3. Acta Diabetologica, 2018 Jun;55(6):627-635 – PMID: 29582161 Sex Differences in the Association of Psychological Status with Measures of Physical Activity and Sedentary Behaviour in Adults with Type 2 Diabetes. Indelicato L*, Dauriz M*, Bacchi E*, Donà S, Santi L, Negri C, Cacciatori V, Bonora E, Nouwen A, Moghetti P. *Equal contribution

3.340

4. Metabolism: Clinical and Experimental, 2018 Jun;83:225-233 – PMID: 29510180 Metabolic Syndrome and Uric Acid Nephrolithiasis: Insulin Resistance in Focus. Spatola L; Ferraro MP; Gambaro G; Badalamenti S; Dauriz M.

5.777

5. PloS ONE, 2018 Feb; 13(2): e0190627 - doi.org/10.1371/journal.pone.0190627 A closed-loop multi-level model of glucose homeostasis Uluseker C, Simoni G, Marchetti L, Dauriz M, Matone A, Priami C.

2.806

6. Nutrition, Metabolism & Cardiovascular Diseases, 2018 Apr;28(4):343-351 – PMID: 29477578 Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) Dauriz M, Bacchi E, Boselli L, Santi L, Negri C, Trombetta M, Bonadonna RC, Bonora E, Moghetti P.

3.679

7. Nutrition, Metabolism & Cardiovascular Diseases, 2018 May;28(5):444-450 – PMID: 29519560 Mortality from infectious diseases in diabetes. Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, Corti MC.

3.679

8. Diabetes Care. 2017;40(5):671-678 – PMID: 29061587 Prognostic impact of diabetes mellitus on long-term survival outcomes in patients with heart failure. A meta-analysis. Dauriz M, Mantovani A, Bonapace S, Verlato G, Zoppini G, Bonora E, Targher G

11.857

9. Journal of the Endocrine Society, 2017 Nov 6 – doi.org/10.1210/js.2017-00300 – PMID: 29379894 Long acting GLP-1 receptor agonist Exenatide influence on the autonomic cardiac sympatho-vagal balance. Cacciatori V, Zoppini G, Bellavere F, Rigolon R, Thomaseth K, Pichiri I, Trombetta M, Dauriz M, De Santi F, Targher G, Santi L, Bonora E

-

10. Journal of Renal Nutrition, 2017 Oct 28 – PMID: 29089278 pii: S1051-2276(17)30196-6. doi: 10.1053/j.jrn.2017.08.008 Probiotic Soy Milk: A call to action. (Letter) Spatola L, Badalementi S, Dauriz M

2.318

11. BMC Pulmonary Medicine, 2017 Jul 17; 17(1):101 – PMID: 28716044 doi: 10.1186/s12890-017-0443-1 Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population. De Santi F, Zoppini G, Locatelli F, Finocchio E, Cappa V, Dauriz M, Verlato G

2.435

12. Journal of The American Heart Association, 2017 Jul 5;6(7) – PMID 28679559 Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. Dauriz M*, Targher G*, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP; GISSI-HF Investigators. *Equal contribution.

4.425

13. Nutrition, Metabolism & Cardiovascular Diseases, 2017 Apr 27(4) 300-306. – PMID:28274728 Psychological distress, self-efficacy and glycemic control in type 2 diabetes Indelicato L, Dauriz M, Santi L, Bonora F, Negri C, Cacciatori V, Targher G, Trento M, Bonora E.

3.679

14. Diabetes Care. 2017 May;40(5):671-678 – PMID:28255009 Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry. Dauriz M*, Targher* G, Laroche C, Temporelli PL, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro M, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L; ESC-HFA Heart Failure Long-Term Registry. *Equal contribution.

11.857

9

Impact Factor JCR 2016

15. Nutrition, Metabolism and Cardiovascular Diseases, 2017 Feb;27(2):99-114 – PMID: 28063875 Genetic prediction of common forms of diabetes mellitus and related chronic complications. Position Statement of the Italian Society of Diabetology. Buzzetti R, Prudente S, Copetti M, Dauriz M, Zampetti S, Garofalo M, Penno G, Trischitta V.

3.679

16. European Journal of Heart Failure 2017 Jan;19(1):54-65 – PMID: 27790816 In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry. Targher G*, Dauriz M*, Tavazzi L, Temporelli PL, Lucci D, Lecchi G, Bellanti G, Merlo M, Maggioni AP on behalf of the ESC EORP-HFLT Registry Investigators. *Equal contribution.

6.968

17. Scientific Reports, 2016 Nov 8; 6: 36029 – PMID:27824066 A parsimonious model of a mixed-meal test in patients with Type 1 diabetes in insulin pump therapy.

Marchetti L*, Reali F*, Dauriz M, Brangani C, Boselli L, Ceradini G, Bonora E, Bonadonna RC, Priami C. *Equal contribution. 4.259

18. American Journal of Human Genetics, 2016 Jul 7;99(1):56-75 – PMID: 27321945 African and European Ancestry Trans-ethnic Meta-Analysis Illuminates the Genetic Architecture of Fasting Glucose and Insulin. [The MAGIC Consortium]

Liu CT, Raghavan S, Maruthur N, Kabagambe E, Hong J, Maggie CY Ng, Hivert MF, Lu Y, An P, Bentley AR, Drolet AM, Gaulton KJ, Hayes MG, Irvin MR, Li M, Lipovich L, Rybin DV, Agyemang C, Allred N, Armstrong LL, Cade BE, Chen WM, Dauriz M, Delaney JAC, Edwards TL, Evans MK, Guo X, Lange LA, Leong A, Liu J, Liu Y, Patel SR, Porneala B, Shriner D, Snijder MB, Snively BM, Stallings S, Tanaka T, Yanek L, Zhao W, Becker DM, Bielak LF, Bottinger EP, Bowden DW, Chen G, Correa A, Couper DJ, Crawford D, Eicher JD, Fox CS, Franceschini N, Fu YP, Goodarzi M, Gottesman O, Hara K, Harris TB, Jensen RA, Johnson AD, Karter AJ, Keller MF, Krauss R, Langefeld CD, Li X, Liang J, Liu S, Lowe WL, Mosley TH, North KE, Peyser PA, Patrick AL, Province MA, Selvin E, Sims M, Tajuddin S, Vaidya D, Wren MP, Yao J, Zhu X, Ziegler JT, Zmuda JM, Zonderman AB, Zwinderman AH, COGENT-BP Consortium, Adeyemo A, Boerwinkle E, Miljkovic I, Pankow JS, Rotimi CN, Sale MM, Wagenknecht LE, Arnett DK, Chen I, Nalls MA, MAGIC Consortium, Borecki I, Siscovick D, Wilson JG, Loos RJF, Dupuis J, Rich SS, Florez JC, Rotter J, Morris AP, Meigs JB

9.025

19. Diabetologia, 2016 Jul;59(7):1400-1402 – PMID: 27115413 The power of numbers. Invited Commentary. Dauriz M, Meigs JB

6.080

20. European Journal of Human Genetics, 2016 Aug;24(9):1337-43 – PMID: 26860063 Association of the IGF1 gene with fasting insulin levels.

Willems SM, Cornes BK, Brody J, Morrison AC, Lipovich L, Dauriz M, Rybin DV, Gibbs RA, Muzny D, Pankow JS, Psaty BM, Boerwinkle E, Rotter JI, Siscovick DS, Vasan RS, Kaplan RC, Isaacs A, Dupuis J, van Duijn CM, Meigs JB.

4.287

21. Nutrition, Metabolism and Cardiovascular Diseases, 2016 Mar;26(3):232-8 – PMID: 26868433 Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5.

Trombetta M*, Dauriz M*, Bonetti S*, Travia D, Boselli L, Santi L, Bonora E, Bonadonna RC. *Equal contribution.

3.679

22. International Journal of Cardiology 2016 Jan 203: 587-593 – PMID: 26574932 Prognostic Impact of In-Hospital Hyperglycemia in Hospitalized Patients With Acute Heart Failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome Registry.

Targher G*, Dauriz M*, Tavazzi L, Temporelli PL, Lucci D, Lecchi G, Bellanti G, Merlo M, Maggioni AP on behalf of the IN-HF Outcome Investigators. *Equal contribution.

6.189

23. Acta Diabetologica, 2016 Jun;53(3):393-402 – PMID: 26538364 Interleukin-6 as positive modulator of human beta cell function: an exploratory analysis from the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).

Dauriz M, Trombetta M, Boselli L, Santi L, Brangani C, Pichiri I, Bonora E, Bonadonna RC.

3.340

24. Diabetes Care, 2015 Aug;38(8):1487-93 – PMID: 26068862

Prevalence of cardiovascular autonomic neuropathy in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed type 2 Diabetes Study (VNDS).

Zoppini G., Cacciatori V., Raimondo D., Gemma L., Trombetta M., Dauriz M., Bergamini C., Brangani C., Pichiri I., Stoico V., Negri C., Bellavere F., Tomaseth K., Targher G., Santi L., Bonadonna R.C., Bonora E.

11.857

25. Metabolism: Clinical and Experimental 2015 Aug; 64(8):879-87 – PMID: 25957758 Heart Valve Calcification in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.

Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Valbusa F, Bertolini L, Zenari L, Pichiri I, Dauriz M, Zoppini G, Barbieri E, Byrne CD, Bonora E, Targher G.

5.777

10

Impact Factor

JCR 2016 26. Circulation: Cardiovascular Genetics 2015 Jun;8(3): 507-15 – PMID: 25805414

Association of a 62 Variants Type 2 Diabetes Genetic Risk Score with Markers of Subclinical Atherosclerosis: a Transethnic, Multicenter Study.

Dauriz M, Porneala BC, Guo X, Bielak LF, Peyser P, Durant NH, Carnethon MR, Bonadonna RC, Bonora E, Bowden DW, Florez JC, Fornage M, Hivert MF, Jacobs D, Kabagambe EK, Lewis CE, Murabito JM, Rasmussen-Torvik LJ, Rich SS, Vassy JL, Yao J, Carr JJ, Kardia SLR, Siscovick DS, O’Donnell C, Rotter JI, Dupuis J and Meigs JB on behalf of the FHS, CARDIA, MESA and GENOA Investigators.

4.743

27. Nature Communications 2015 Jan 29;6:5897 – PMID: 25631608 Rare, low frequency, and common exome chip variants are associated with fasting glucose and influence type 2 diabetes susceptibility - The CHARGE T2D-Glycemia Exome Consortium. Wessel J*, Chu AY*, Willems SM*, Wang S*, Yaghootkar H, Brody JA, Dauriz M, Hivert MF, Raghavan S, Lipovich L, Hidalgo B, Fox K, Huffman JE, An P, Lu Y, Rasmussen-Torvik LJ, Grarup N, Ehm MG, Li L, Baldridge AS, Stančáková A, Abrol R, Besse C, Boland A, Bork-Jensen J, Fornage M, Freitag DF, Garcia ME, Guo X, Hara K, Isaacs A, Jakobsdottir J, Lange LA, Layton JC, Man Li, Hua Zhao J, Meidtner K, Morrison AC, Nalls MA, Peters MJ, Sabater-Lleal M, Schurmann C, Silveira A, Smith AV, Southam L, Stoiber MH, Strawbridge RJ, Taylor KD, Varga TV, Allin KH, Amin N, Aponte JL, Aung T, Barbieri C, Bihlmeyer NA, Boehnke M, Bombieri C, Bowden DW, Burns SM, Chen Y, Chen Y-D I, Cheng CY, Correa A, Czajkowski J, Dehghan A, Georg B. Ehret, Eiriksdottir G, Escher SA, Farmaki AE, Frånberg M, Gambaro G, Giulianini F, Goddard III WA, Goel A, Gottesman O, Grove ML, Gustafsson S, Hai Y, Hallmans G, Heo J, Hoffmann P, Ikram MK, Jensen RA, Jørgensen ME, Jørgensen T, Karaleftheri M, Khor CC, Kirkpatrick A, Kraja AT, Kuusisto J, Lange EM, Lee IT, Lee WJ, Leong A, Liao J, Liu C, Liu Y, Lindgren CM, Linneberg A, Malerba G, Mamakou V, Marouli E, Maruthur NM, Matchan A, McKean R, McLeod O, Metcalf GA, Mohlke KL, Muzny DM, Ntalla I, Palmer ND, Pasko D, Peter A, Rayner NW, Renström F, Rice K, Sala CF, Sennblad B, Serafetinidis I, Smith JA, Soranzo N, Speliotes EK, Stahl EA, Stirrups K, Nikos Tentolouris, Thanopoulou A, Torres M, Traglia M, Tsafantakis E, Javad S, Yanek LR, Zengini E, Becker DM, Bis JC, Brown JB, L. Cupples A, Hansen T, Ingelsson E, Andrew J. Karter, Carlos Lorenzo, Rasika A. Mathias, Jill M. Norris, Gina M. Peloso, Wayne H.-H. Sheu, Toniolo D, Vaidya D, Varma R, Wagenknecht LE, Boeing H, Erwin P. Bottinger, George Dedoussis, Deloukas P, Ferrannini E, Franco OH, Franks PW, Gibbs RA, Gudnason V, Hamsten A, Harris TB, Andrew T. Hattersley, Hayward C, Hofman A, Jansson JH, Langenberg C, Launer LJ, Levy D, Ben A. Oostra, O'Donnell CJ, O’Rahilly S, Padmanabhan S, Pankow JS, Polasek O, Province MA, Rich SS, Ridker PM, Rudan I, Schulze MB, Smith BH, Uitterlinden AG, Walker M, Watkins H, Wong TY, Zeggini E, Generation Scotland, The EPIC-InterAct Consortium, Laakso M, Borecki IB, Daniel I. Chasman, Oluf Pedersen, Bruce M. Psaty, E. Shyong Tai, van Duijn CM, Wareham NJ, Waterworth DM, Boerwinkle E, Kao WHL, Florez JC, Loos RJF, Wilson JG, Frayling TM, Siscovick DS, Dupuis J, Rotter JI, Meigs JB, Scott RA, Goodarzi MO. *These authors contributed equally to this work.

12.124

28. Diabetes Care 2014 Sep; 37(9):2508-14 – PMID: 24947790 Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Walford GA, Porneala BC, Dauriz M, Vassy JL, Cheng S, Rhee EP, Wang TJ, Meigs JB, Gerszten RE, Florez JC.

11.857

29. Circulation: Cardiovascular Genetics 2014 Jun; 7(3):374-82 – PMID: 24951664 Association of Levels of Fasting Glucose and Insulin with Rare Variants at the Chromosome 11p11.2-MADD Locus: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study. Cornes BK, Brody JA, Naghmeh N, Morrison AC, Dang HCP, Ahn BS, Wang S, Dauriz M, Barzilay JI, Dupuis J, Florez JC, Coresh J, Gibbs AG, Kao WHL, Liu CT, McKnight B, Muzny D, Pankow JS, Reid JG, White CC, Johnson AD, Wong TY, Psaty BM, Boerwinkle E, Rotter JI, Siscovick DS, Sladek R, and Meigs JB, on behalf of the CHARGE Targeted Sequencing Study Diabetes working group.

4.743

30. Diabetes 2014 Jun; 63(6): 2172-82 – PMID: 24520119 Polygenic type 2 diabetes prediction at the limit of common variant detection Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C, Meigs JB.

8.684

31. Curr Cardiovasc Risk Rep (2014) 8(1):368 - PMID: 24729826 Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease. Dauriz M, Meigs JB.

-

32. Clin Sci (Lond). 2013 Sep; 125(6):301-9 – PMID: 23596966 Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. Targher G, Mantovani A, Pichiri I, Rigolon R, Dauriz M, Zoppini G, Morani G, Vassanelli C, Bonora E.

4.936

11

Scientific Publications as working group collaborator Impact Factor JCR 2016

1. Journal of the American Society of Nephrology, 2017 Mar;28(3):981-994 – PMID:27920155 SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. Li M, Li Y, Weeks O, Mijatovic V, Teumer A, Huffman JE, Tromp G, Fuchsberger C, Gorski M, Lyytikäinen LP, Nutile T, Sedaghat S, Sorice R, Tin A, Yang Q, Ahluwalia TS, Arking DE, Bihlmeyer NA, Böger CA, Carroll RJ, Chasman DI, Cornelis MC, Dehghan A, Faul JD, Feitosa MF, Gambaro G, Gasparini P, Giulianini F, Heid I, Huang J, Imboden M, Jackson AU, Jeff J, Jhun MA, Katz R, Kifley A, Kilpeläinen TO, Kumar A, Laakso M, Li-Gao R, Lohman K, Lu Y, Mägi R, Malerba G, Mihailov E, Mohlke KL, Mook-Kanamori DO, Robino A, Ruderfer D, Salvi E, Schick UM, Schulz CA, Smith AV, Smith JA, Traglia M, Yerges-Armstrong LM, Zhao W, Goodarzi MO, Kraja AT, Liu C, Wessel J; CHARGE Glycemic-T2D Working Group; CHARGE Blood Pressure Working Group, Boerwinkle E, Borecki IB, Bork-Jensen J, Bottinger EP, Braga D, Brandslund I, Brody JA, Campbell A, Carey DJ, Christensen C, Coresh J, Crook E, Curhan GC, Cusi D, de Boer IH, de Vries AP, Denny JC, Devuyst O, Dreisbach AW, Endlich K, Esko T, Franco OH, Fulop T, Gerhard GS, Glümer C, Gottesman O, Grarup N, Gudnason V, Harris TB, Hayward C, Hocking L, Hofman A, Hu FB, Husemoen LL, Jackson RD, Jørgensen T, Jørgensen ME, Kähönen M, Kardia SL, König W, Kooperberg C, Kriebel J, Launer LJ, Lauritzen T, Lehtimäki T, Levy D, Linksted P, Linneberg A, Liu Y, Loos RJ, Lupo A, Meisinger C, Melander O, Metspalu A, Mitchell P, Nauck M, Nürnberg P, Orho-Melander M, Parsa A, Pedersen O, Peters A, Peters U, Polasek O, Porteous D, Probst-Hensch NM, Psaty BM, Qi L, Raitakari OT, Reiner AP, Rettig R, Ridker PM, Rivadeneira F, Rossouw JE, Schmidt F, Siscovick D, Soranzo N, Strauch K, Toniolo D, Turner ST, Uitterlinden AG, Ulivi S, Velayutham D, Völker U, Völzke H, Waldenberger M, Wang JJ, Weir DR, Witte D, Kuivaniemi H, Fox CS, Franceschini N, Goessling W, Köttgen A, Chu AY.

8.966

2. Nephrol Dial Transplant 2014 Mar; 29(3):657-62 – PMID: 24398892 Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. De Cosmo S, Rossi MC, Pellegrini F, Lucisano G, Bacci S, Gentile S, Ceriello A, Russo G, Nicolucci A, Giorda C, Viazzi F, Pontremoli R; AMD-Annals Study Group.

4.470

3. 2010 AMD Annals (2010 Annals of Italian Association of Clinical Diabetologists) Quality Indicators of Diabetes Care in Italy – 2010 Acler P, Romanelli T, Inchiostro S., Dauriz M, Regional Diabetes Center of Trento City Hospital, Trento, Italy - as part of The AMD Annals 2010 Working Group

-

Responses to Comments to Authors Impact Factor JCR 2016

1. Diabetes 2014 Jul; 63(7): e13 – PMID: 24962928 Response to comment on Vassy et al. “Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182” Vassy JL, Hivert MF, Dauriz M, Meigs JB

8.684

12

Abstract congressuali 2018

- Dauriz M., Drezza L., Santi L., Altomari A., Rinaldi E., Tardivo S., Bovo C., Ribichini F., Bonora E. ”Current Impact Of Diabetes On In-Hospital Survival And Complication Outcomes In Acute Coronary Syndrome” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018 & as Abstract at the 78th American Diabetes Association Annual Meeting, Jun 22-26th 2017 in Orlando, FL, USA

- Olioso D., Donà S., Dauriz M., Bacchi E., Bonora E. ”Effects of aerobic exercise on the expression profile of circulating miRNAs in gestational diabetes mellitus.” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018 & as Abstract at the 78th American Diabetes Association Annual Meeting, Jun 22-26th 2017 in Orlando, FL, USA

- Olioso D., Dauriz M., Bacchi E., Negri C., Bonora E., Moghetti P. ”Effects of aerobic and resistance training on circulating micro-RNA expression profile in subjects with type 2 diabetes” – Accepted as Poster Presentation at the 78th American Diabetes Association Annual Meeting, Jun 22-26th 2017 in Orlando, FL, USA

- Trombetta M., Marchetti L., Reali F., Dauriz M., Brangani C., Santi L., Boselli M.L., Bonora E., Bonadonna R.C. ”Mathematical model analysis of the glucose/insulin system during Mixed Meal Test in individuals with type 1 diabetes on Sensor Augmented Pump (SAP) therapy.” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018 & as Abstract at the 78th American Diabetes Association Annual Meeting, Jun 22-26th 2017 in Orlando, FL, USA

- Cioccoloni D., Imbriaco C., Dauriz M., De Santi F., Mantovani A., Targher G., Bonora E., Zoppini G. ” Clinical insights on the echocardiographic phenotypes in patients with type 2 diabetes” – Accepted as Poster Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018

- Imbriaco C., Cioccoloni D., Dauriz M., De Santi F., Mantovani A., Targher G., Bonora E., Zoppini G. ”Electrocardiographic voltage reduction as a potential biomarker of cardiac fibrosis in type 2 diabetes” – Accepted as Poster Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018

- Indelicato L, Dauriz M., Santi L., Negri C., Cacciatori V., Pichiri I., Brangani C., Bonora E. ”Self-care behaviour and psychological distress in diabetic individuals with and without major depression” – Accepted as Poster Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018

- Mantovani A., Dauriz M., Turino T., Rigolon R., Zoppini G., Bonora E., Targher G. ”Nonalcoholic fatty liver disease and risk of colorectal tumours: a meta-analysis” – Accepted as Poster Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018

- Maneschi C., Dauriz M., Castelli C., Tomezzoli A., Fuini A., Landoni L., Ferdeghini M., Bonora E., Moghetti P. ”Insulinoma relapse in adult nesidioblastosis: medical and surgical treatment.” – Case Report submitted to the “Endocrinology and Metabolism Meeting 2018” organized by the Italian Society of Endocrinology, 10-11 May 2018 in Bari, Italy 2017

- Dauriz M., Trombetta M., Santi L., Boselli L., Brangani C., Pichiri I., Travia D., Cacciatori V., Negri C., Stoico V., Bonadonna RC, Bonora E.” Relationship of chronic vascular complications with beta cell dysfunction and insulin resistance in newly-diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)” – Accepted as Oral Poster Presentation at the 77th American Diabetes Association Annual Meeting, Jun 9-13th 2017 in San Diego, CA, USA & as Oral Poster Presentation at the 53rd European Association for the Study of Diabetes Annual Meeting, September 11-15, 2017 in Lisbon, Portugal & as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2018

- Mantovani A., Dauriz M., Rigolon R., Isabella P., Bonapace S., Morani G., Zoppini G., Bonora E., Targher G. ”Nonalcoholic Fatty Liver Disease Is Independently Associated With An Increased Risk of Heart Block in Hospitalized Patients With Type 2 Diabetes” – Accepted as Poster Presentation at the 77th American Diabetes Association Annual Meeting, Jun 9-13th 2016 in San Diego, CA, USA 2016

- Dauriz M., Zusi C., Trombetta M., Santi L., Boselli L., Travia D., Bonora E., Bonadonna R.C.” Association of OPG and RANKL loci with insulin sensitivity/secretion and cardiovascular risk traits. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).” – Accepted as Poster Presentation at the 76th American Diabetes Association Annual Meeting, Jun 10-14th 2016 in New Orleans, LA, USA

13

- Dauriz M., Targher G., Laroche C., Temporelli P.L., Barge-Caballero E., Nanas J., Crespo-Leiro M.G., Maggioni A.P., Tavazzi L.” Association of OPG and RANKL loci with insulin sensitivity/secretion and cardiovascular risk traits. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).” – Accepted as Poster Presentation at the Heart Failure 2016 European Society of Cardiology (ESC) Scientific Meeting - 3rd World Congress on Acute Heart Failure, May 21-24th 2016 in Florence, Italy

- Dauriz M., Targher G., Laroche C., Temporelli P.L., Alonso-Pulpon L., Celic V., Coats A.J., Crespo-Leiro M.G., Maggioni A.P., Tavazzi L. ”Diabetes is associated with long-term adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure. Results from the ESC-HFA Long-Term Heart Failure Registry.” – Accepted as Rapid Fire Abstract at the Heart Failure 2016 European Society of Cardiology (ESC) Scientific Meeting - 3rd World Congress on Acute Heart Failure, May 21-24th 2016 in Florence, Italy

- Indelicato L., Bacchi E., Negri C., Dauriz M., Donà S., Moghetti P., Bonora E. “Physical activity is associated with different psychological status in men and women affected by type 2 diabetes” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2016

- Indelicato L., Negri C., Dauriz M., Brangani C., Santi L., Boselli L., Trombetta M., Bonora E. “Psychological Impact of Insulin Pump Therapy in Adults affected by Type 1 Diabetes” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2016

- Bacchi E., Dauriz M., Negri C., Santi L., Boselli L., Trombetta M., Bonadonna R.C., Bonora E., Moghetti P. ”Moderate daily physical activity is positively associated with insulin sensitivity, but not with beta cell function in patients with newly diagnosed type 2 diabetes” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2016

- Zusi C., Trombetta M., Dauriz M., Bonetti S., Boselli L., Travia D., Bonora E., Bonadonna R.C. ”Association of osteoprotegerin with insulin sensitivity/secretion and subclinical atherosclerosis traits. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).” – Accepted as Oral Presentation at the XXVI National Congress of Italian Society of Diabetology – Rimini, Italy 2016 2015

- Dauriz M., Bacchi E., Negri C., Santi L., Boselli L., Trombetta M., Bonadonna R.C., Bonora E., Moghetti P. ”Moderate daily physical activity is positively associated with insulin sensitivity, but not with beta cell function in patients with newly diagnosed type 2 diabetes” – Accepted as Oral Presentation at the Regional Joint Congress of the Italian Society of Diabetes and the Italian Association of Clinical Diabetologists, Nov 6-7th 2015, Trento, Italy

- Dauriz M., Trombetta M., Bonetti S., Travia D., Boselli L., Santi L., Bonora E., Bonadonna R.C. ”Association of common genetic variation at IRS1, ENPP1 and TRIB3 loci with metabolic phenotype and cardiovascular risk traits in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed type 2 Diabetes Study (VNDS). – accepted as Oral presentation at the XVI Annual Meeting of the Italian Society for the Study of Atherosclerosis – North-East Section, 16th May 2015, Verona, Italy

- Dauriz M., Bonadonna R.C., Trombetta M., Boselli L., Santi L., Brangani C., Pichiri I., Bianchi C., Miccoli R., Del Prato S., Bonora E. “Pancreatic Beta-cell Function, Insulin Sensitivity and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis. The Verona Newly Diagnosed type 2 Diabetes Study (VNDS).” – accepted as Poster presentation at the 75th American Diabetes Association Annual Meeting, 2015 in Boston, MA, as Oral presentation at the 38th Italian Society of Endocrinology Annual Meeting, 27th-30th May 2015, Taormina, Italy, and as Oral Presentation at the 51st European Association for the Study of Diabetes Annual Meeting, September 14-18, 2015 in Stockholm, Sweden

- Dauriz M., Porneala, BC, Dupuis J, Murabito JM, Cupples AL, Florez JC, MD, Meigs JB. “A Genetic Risk Score of 96 Variants linked with Type 2 Diabetes and Cardiometabolic Risk Traits is Associated with Cardiovascular Mortality in 29-years Follow-up of the Framingham Heart Study (FHS).” – accepted as Poster presentation to the 75th American Diabetes Association Annual Meeting, 2015 in Boston, MA

- Mantovani A., Dauriz M., Pichiri I., Pernigo M., Bergamini C., Bonapace S., Bonora E., Targher G. “Nonalcoholic Fatty Liver Disease is associated with Heart Valve Calcification in Type 2 Diabetes.” – accepted as Poster Guided Audio Tour to the 75th American Diabetes Association Annual Meeting, 2015 in Boston, MA

- Trombetta M., Zusi C., Bonetti S., Dauriz M., Travia D., Bonora E., Bonadonna R.C. “Interaction between common genetic variability of osteoprotegerin (OPG), beta cell function and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes.” – accepted as Oral Presentation at the 38th Italian Society of Endocrinology Annual Meeting, 27th-30th May 2015, Taormina, Italy

- Brangani C., Dauriz M., Boselli L., Reali F., Marchetti L., Ceradini G., Rubbo I., Trombetta M., Priami C., Bonadonna R.C. “A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy.” – accepted as Poster Presentation at the 51st European Association for the Study of Diabetes Annual Meeting, September 14-18, 2015 in Stockholm, Sweden

14

2014

- Dauriz M., Zusi C., Trombetta M., Bonetti S., Boselli M.L., Travia D., Zoppini G., Bonora E., Bonadonna R.C. “Association of a 44 Variants Nephropathy Genetic Risk Score with Reduced Glomerular Filtration Rate in Patients with Newly Diagnosed Type 2 Diabetes” – Accepted as Oral Presentation at the Regional Joint Congress of the Italian Society of Diabetes and the Italian Association of Clinical Diabetologists, Nov 24th 2014, Verona, Italy

- Zusi C., Bonetti S., Trombetta M., Boselli ML., Dauriz M., Bonora E., Bonadonna RC. “Genotype/phenotype interactions between the “osteokine” network and the glucose/insulin system in patients with newly diagnosed type 2 diabetes mellitus” – Accepted as Oral Presentation at the Regional Joint Congress of the Italian Society of Diabetes and the Italian Association of Clinical Diabetologists, Nov 24th 2014, Verona, Italy

- Indelicato L., Negri C., Dauriz M., Brangani C., Santi L., Boselli L., Trombetta M., Bonora E. “Psychological Aspects and Insulin Pump Therapy in Adults affected by Type 1 Diabetes: a Preliminary Study” – Accepted as Oral Presentation at the Regional Joint Congress of the Italian Society of Diabetes and the Italian Association of Clinical Diabetologists, Nov 24th 2014, Verona, Italy

- Raghavan S, Leong A, Dauriz M, Liu CT, Dupuis J, Florez JC, Meigs JB. “Quantitative glycemic trait genetic loci are enriched for common variants with regulatory potential compared with type 2 diabetes risk loci.” – Accepted as Late Breaking Abstract (Poster Session) to the 74th American Diabetes Association Annual Meeting, June 13-17, 2014 in San Francisco, CA

- Goodarzi M and the CHARGE glycaemia T2D Working Group. “Exomes in Glycemia and Type 2 Diabetes - CHARGE” – Accepted as Oral Presentation to the 74th American Diabetes Association Annual Meeting, June 13-17, 2014 in San Francisco, CA

- Chu AY, Hidalgo B, Wang S, Chen Y, Willems SM, Scott RA, Dauriz M, An P, Baldridge A, Huffman JE, Guo X, Jensen RA, Lange L, Li M, Liao J, Lu Y, Meidtner K, Nalls MA, Smith AV, Southam L, Strawbridge RJ, Hivert MF, Rotter JI, Siscovick DS, Dupuis J, Meigs JB, Wessel J, Goodarzi MO – CHARGE glycaemia T2D Exome Chip Working Group. “Exome Chip Analysis of 9,990 Type 2 Diabetes (T2D) Cases and 51,945 Controls Identifies Novel Rare and Low Frequency Coding Variation in Known T2D Susceptibility Loci.” – Accepted as Oral Presentation to the 74th American Diabetes Association Annual Meeting, June 13-17, 2014 in San Francisco, CA

- Wessel J, Wang S, Scott R, Chu A, Willems S, Hivert MF, An P, Lu Y, Lange L, Wilson J, Huffman M, Dauriz M, Jensen RA, Hidalgo B, Loos R, Yaghootkar H, Fraylin TF, Baldridge A, Li M, Rasmussen-Torvik LJ, Nalls MA, Meidtner K, Guo X, Pasko D, Southam L, Strawbridge RJ, Jakosdottir J, Smith A, Lange E, Layton J, Siscovick DS, Rotter JI, Dupuis J, Meigs JB, Goodarzi MO. “Rare and Common Exome Variants are Associated with Fasting Glucose and Insulin Levels - The CHARGE-S Exome Chip and Sequencing Study.” – accepted as Oral Presentation to the 74th American Diabetes Association Annual Meeting, June 13-17, 2014 in San Francisco, CA

- Dauriz M., Porneala BC., Guo X, Bielak LF., Durant NH., Meigs JB on behalf the FHS, MESA, GENOA and CARDIA Investigators “A 62 Variant Type 2 Diabetes Genetic Risk Score is not associated with Markers of Subclinical Atherosclerosis in Multiethnic Cohorts: the Framingham Heart Study (FHS), Genetic Epidemiology Network of Atherosclerosis (GENOA), Multi-Ethnic Study of Atherosclerosis (MESA), and Coronary Artery Risk Development in Young Adults (CARDIA) Studies.” – Accepted as Poster Guided Audio Tour to the 74th American Diabetes Association Annual Meeting, June 13-17, 2014 in San Francisco, CA 2013

- Dauriz M., Porneala BC, Vassy JL, Hivert MF, Murabito JM, Florez JC, Dupupis J, O’Donnell CJ, Meigs, JB. “A 62 variant type 2 diabetes genetic risk score is not associated with subclinical atherosclerosis in the Framingham Heart Study – SNP Health Association Resource (The FHS SHARe Study).” (2161T) – Poster presentation at the 63rd Annual Meeting of The American Society of Human Genetics, October 22-26, 2013 in Boston, MA

- Wessel J et al. on behalf of the CHARGE Consortium - Diabetes working group. “Rare and Common Exome Chip Variants are Associated with Fasting Glucose and Insulin Levels - The CHARGE-S Exome Chip and Sequencing Study.” (2232W) – Poster presentation at the 63rd Annual Meeting of The American Society of Human Genetics, October 22-26, 2013 in Boston, MA

- Trombetta M, Brangani C, Boselli L, Negri C, Dauriz M, Rubbo I, Ceradini C, Bonora E and Bonadonna RC. “Quantitation of the roles played by the main determinants of after meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy” (1101) – Poster presentation at the 49th European Association for the Study of Diabetes, September 23-27, 2013 in Barcelona, Spain

- Brangani C, Boselli L, Dauriz M, Bonadonna RC, Bonora E, Trombetta M. “Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes.” (625) – Poster presentation at the 49th European Association for the Study of Diabetes, September 23-27, 2013 in Barcelona, Spain

- Fainelli G, Bonadonna RC, Trombetta M, Boselli L, Bonetti S, Stoico V, Negri C, Dauriz M, Bonora E. “In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months” (643) – Poster presentation at the 49th European Association for the Study of Diabetes, September 23-27, 2013 in Barcelona, Spain

- Dauriz M., Mantovani A., Pichiri I., Rigolon R., Zoppini G., Bonora E., Targher G. “Non-Alcoholic Fatty Liver Disease is associated with an increased prevalence of atrial fibrillation in patients with type 2 diabetes “ (1418P) - Poster presentation at the 73rd American Diabetes Association Annual Meeting, June 21-25, 2013 in Chicago, IL

15

2012

- Trombetta M, Bonetti S., Boselli L., Dauriz M., Malerba G., TrabettiE., Pignatti PF, Bonora E., Bonadonna RC. “Common Variants of Monogenic Diabetes Genes Influence Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes” (1724P) - Poster presentation at the 72nd American Diabetes Association Annual Meeting, June 8-12, 2012 in Philadelphia, PA

- Bonetti S., Trombetta M., Boselli L., Dauriz M., Malerba G., Trabetti E., Pignatti P., Bonora E., Bonadonna RC. “Common variants of monogenic diabetes genes may affect beta-cell functional mass in patients with newly diagnosed type 2 diabetes” – Poster presentation at the 15th International & 14th European Congress of Endocrinology (ICE/ECE 2012) – Firenze 2012 – Endocrine Abstracts (29) OC3.1, May 2012

- Dauriz M., Boselli L., Brangani C., Bonadonna R. C., Bonora E., Trombetta M. “Does IL-6 be a positive modulator of beta cell function? A study on newly diagnosed type 2 diabetic patients/ IL-6 è un modulatore positivo della funzione beta cellulare in vivo? Uno studio su pazienti con diabete di tipo 2 neodiagnosticato.” - Poster presentation at the XXIV National Congress of Italian Society of Diabetes – Torino, Italy 2012 - il Diabete (supplement I to n. 1), Mar 2012

- Brangani C., Boselli L., Dauriz M., Bonadonna R. C., Bonora E., Trombetta M. “Uric acid and beta cell function in newly diagnosed type 2 diabetic patients/ Acido urico e funzione beta cellulare in pazienti affetti da diabete mellito di tipo 2 di nuova diagnosi” - Poster presentation at the XXIV National Congress of Italian Society of Diabetes – Torino, Italy 2012 - il Diabete (supplement I to n. 1), Mar 2012 Altri contributi

2016

- Chapter book. Contributed as author to the “Genetic Counseling and Diabetes / Consulenza genetica e diabete” chapter, included in: “Il diabete in Italia / The status of diabetes in Italy”, curated by Bonora E. and Sesti G. ISBN 978-88-6923-146-9, pp. 135-142, April 2016, Bononia University Press (language: Italian) 2015

- Original research article. Contributed to discussions related to statistical analysis in: PLoS One 2015 Mar 26; 10(3): e0121553 – PMID: 25812009

The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes. Walford GA, Colomo N, Todd JN, Billings LK, Fernandez M, Charmarthi B, Warner AS, Davis J, Littleton KR, Hernandez AM, Fanelli RR, Lanier A, Barbato C, Ackerman RJ, Khan SQ, Bui R, Garber L, Stolerman ES, Moore AF, Huang C, Kaur V, Harden M, Taylor A, Chen L, Manning AK, Huang P, Wexler D, McCarthy RM, Lo J, Thomas MK, Grant RW, Goldfine A, Hudson MD, Florez JC. 2014

- Chapter book. Contributed as consultant to define the minimal models for the IVGTT described in: Applications of Membrane Computing in Systems and Synthetic Biology Emergence, Complexity and Computation Vol. 7, 2014, pp 223-245, Chapter: "MP Modelling for Systems Biology: Two Case Studies". Marchetti L. et al.

In fede,

Verona, 19 luglio 2018

Autorizzo il trattamento dei miei dati personali ai sensi del Decreto Legislativo 30 giugno 2003, n. 196 "Codice in materia di protezione dei dati personali”

Autorizzo l'Università di Verona a pubblicare sul sito web istituzionale dell'Ateneo, il mio curriculum vitae, nella forma da me redatta, secondo quanto previsto dall'art. 15 del D.Lgs. n. 33/2013